Astec LifeSciences Limited (NSE:ASTEC)
India
· Delayed Price · Currency is INR 700.40
-26.35 (-3.63%)
Apr 29, 2026, 3:29 PM IST
Astec LifeSciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Net Income | -809.18 | -1,348 | -469.3 | 255.65 | 898.59 | Upgrade
|
| Depreciation & Amortization | 449.22 | 433.07 | 358.17 | 328.56 | 336.55 | Upgrade
|
| Other Amortization | - | 4.07 | 4.37 | 7.96 | 7.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.66 | -20.18 | 1.11 | 5.24 | -0.14 | Upgrade
|
| Stock-Based Compensation | 0.93 | 0.35 | 3.01 | 3.31 | 1.05 | Upgrade
|
| Provision & Write-off of Bad Debts | 8.07 | 0.48 | 0.58 | 0.2 | 0.04 | Upgrade
|
| Other Operating Activities | 322.19 | 580.48 | 99.33 | 204.71 | 116.84 | Upgrade
|
| Change in Accounts Receivable | -920.82 | 188.84 | -135.12 | 1,216 | -836.83 | Upgrade
|
| Change in Inventory | 206.35 | 158.68 | 989.1 | -1,088 | -831.42 | Upgrade
|
| Change in Accounts Payable | 43.26 | -77.53 | -888.04 | -142.75 | 607.15 | Upgrade
|
| Change in Other Net Operating Assets | -107.75 | -4.71 | 139 | -44.33 | -62.79 | Upgrade
|
| Operating Cash Flow | -807.08 | -83.99 | 102.21 | 746.56 | 236.04 | Upgrade
|
| Operating Cash Flow Growth | - | - | -86.31% | 216.28% | - | Upgrade
|
| Capital Expenditures | -55.36 | -218.22 | -1,355 | -1,173 | -1,040 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.01 | 59.68 | 3.6 | 7.77 | 1.24 | Upgrade
|
| Other Investing Activities | 5.29 | 6.24 | -0.43 | 39.75 | -0.12 | Upgrade
|
| Investing Cash Flow | -43.06 | -152.3 | -1,352 | -1,125 | -1,039 | Upgrade
|
| Short-Term Debt Issued | 519.71 | 100 | - | 1,277 | 920.27 | Upgrade
|
| Long-Term Debt Issued | - | 1,610 | 1,990 | 586 | - | Upgrade
|
| Total Debt Issued | 519.71 | 1,710 | 1,990 | 1,863 | 920.27 | Upgrade
|
| Short-Term Debt Repaid | -100 | -269.55 | -40.12 | -830 | - | Upgrade
|
| Long-Term Debt Repaid | -1,511 | -817.61 | -439.65 | -427 | - | Upgrade
|
| Total Debt Repaid | -1,611 | -1,087 | -479.77 | -1,257 | - | Upgrade
|
| Net Debt Issued (Repaid) | -1,091 | 622.85 | 1,510 | 606.48 | 920.27 | Upgrade
|
| Issuance of Common Stock | 2,362 | 0.02 | 0.79 | 1.31 | 2.99 | Upgrade
|
| Common Dividends Paid | - | - | -29.41 | -29.41 | -29.38 | Upgrade
|
| Other Financing Activities | -325.92 | -385.54 | -232.03 | -200.68 | -89.1 | Upgrade
|
| Financing Cash Flow | 944.87 | 237.33 | 1,250 | 377.7 | 804.78 | Upgrade
|
| Net Cash Flow | 94.74 | 1.04 | -0.02 | -0.81 | 2.16 | Upgrade
|
| Free Cash Flow | -862.44 | -302.21 | -1,253 | -426.03 | -803.74 | Upgrade
|
| Free Cash Flow Margin | -19.03% | -7.93% | -27.32% | -6.78% | -11.87% | Upgrade
|
| Free Cash Flow Per Share | -40.28 | -15.41 | -63.88 | -21.73 | -41.01 | Upgrade
|
| Cash Interest Paid | - | 385.54 | 232.03 | 200.68 | 89.1 | Upgrade
|
| Cash Income Tax Paid | - | -49.92 | 19.65 | 48.9 | 291.5 | Upgrade
|
| Levered Free Cash Flow | -904.2 | -230.84 | -1,337 | -673.05 | -1,486 | Upgrade
|
| Unlevered Free Cash Flow | -688.4 | -4.12 | -1,182 | -547.06 | -1,432 | Upgrade
|
| Change in Working Capital | -778.96 | 265.27 | 104.94 | -59.06 | -1,124 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.